ZOM Insider Trading Activity and SEC Form 4 Filings
ZOM insider trading summary
No open-market insider purchases or sales of Zomedica Corp. (ZOM) have been reported on SEC Form 4 in the past 12 months.
Latest ZOM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 17, 2025 | Jeffrey M Rowe | Insider | Buy | $5K (68,000 @ $0.07) |
| Mar 17, 2025 | Anthony K Blair | COO | Buy | $30K (500,000 @ $0.06) |
| Mar 17, 2025 | Larry C Heaton II | CEO | Buy | $12K (191,817 @ $0.06) |
| Mar 17, 2025 | Johnny D Powers | Insider | Buy | $7K (100,000 @ $0.07) |
| Mar 17, 2025 | Johnny D Powers | Insider | Buy | $3K (50,000 @ $0.07) |
| Mar 17, 2025 | Johnny D Powers | Insider | Buy | $7K (100,000 @ $0.07) |
| Mar 17, 2025 | Johnny D Powers | Insider | Buy | $7K (100,000 @ $0.07) |
| Mar 17, 2025 | Johnny D Powers | Insider | Buy | $4K (50,000 @ $0.07) |
| Mar 17, 2025 | Johnny D Powers | Insider | Buy | $7K (100,000 @ $0.07) |
| Mar 17, 2025 | Larry C Heaton II | CEO | Buy | $540 (10,000 @ $0.05) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.